1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Catalyst Biosciences: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B MarzAA - Hemophilia A With Inhibitor, Hemophilia B With Inhibitor | Phase 3 | Terminated | Catalyst Biosciences | 18 | 2021-05-04 | 2021-12-17 |
Armenia (1) · Georgia (1) · Hungary (1) · India (1) · Italy (1) · Malaysia (1) · Mexico (1) · Poland (1) · Russia (1) · South Africa (1) · Spain (1) · Taiwan (1) · Turkey (Türkiye) (1) · Ukraine (1) · United Kingdom (1)